Status: current, Defined. Date: 30-Nov 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4755141000168115 | cannabidiol 50 mg / 1 mL + delta-9-tetrahydrocannabinol less than 0.2 mg/mL oral oil, 50 mL (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4755151000168118 | delta-9-tetrahydrocannabinol less than 0.2 mg/mL + cannabidiol 50 mg/mL oral oil, 50 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| delta-9-tetrahydrocannabinol less than 0.2 mg/mL + cannabidiol 50 mg/mL oral oil, 50 mL | Is a | cannabidiol 50 mg/mL oral oil, 50 mL | true | Inferred relationship | Some | ||
| delta-9-tetrahydrocannabinol less than 0.2 mg/mL + cannabidiol 50 mg/mL oral oil, 50 mL | has MPUU | delta-9-tetrahydrocannabinol less than 0.2 mg/mL + cannabidiol 50 mg/mL oral oil | true | Inferred relationship | Some | 1342428047 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| LGP Classic CBD 50 (CBD 50:THC 0.2) oral oil, 50 mL | Is a | True | delta-9-tetrahydrocannabinol less than 0.2 mg/mL + cannabidiol 50 mg/mL oral oil, 50 mL | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR